Israel's Teva Pharm to start paying US opioid settlement in 2023 -CEO - The Jerusalem Post
Teva looks to amp up research collaborations, CEO says
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Israeli authorities cut Teva some slack as foreign bribery case resolved amid other big problems | Fierce Pharma
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Pharmaceutical in $4.35 opioid settlement with states, Native American tribes (TEVA) | Seeking Alpha
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva shed 37% of Israel workforce in two years - Globes
Teva Pharmaceutical's Sales Slump 18% - WSJ
Teva to pay NIS 75 million to Israel authorities to settle foreign bribe claims | The Times of Israel
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva to lay off 350 employees in Israel | ערוץ 7
Teva relocates headquarters in Israel
FDA Requests More Data on Potential New Treatment for Huntington Disease
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
Israeli Teva reaches proposed $4.35 bln settlement of US opioid lawsuits - The Jerusalem Post
Israel's Teva gives upbeat outlook as restructuring proceeds
